Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KISS1R | Q969F8 | 5/20 | 0.65 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.61 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.61 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.61 |
| ▸ | TACR1 | P25103 | 1/20 | 0.59 |
| ▸ | NTSR2 | O95665 | 3/20 | 0.59 |
| ▸ | NTSR1 | P30989 | 3/20 | 0.59 |
| ▸ | SORT1 | Q99523 | 2/20 | 0.59 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.59 |
| ▸ | ABCC2 | Q92887 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Venorphin SCHEMBL29489924 | 0.88 | NPBWR1 (0.65) | KISS1ROPRD1OPRM1OPRK1TACR1 | |
| SCHEMBL29772142 | 0.88 | KISS1R (0.64) | KISS1ROPRD1OPRM1TACR1NTSR2 | |
| SCHEMBL30888410 | 0.87 | KISS1R (0.60) | KISS1RTACR1NTSR2NTSR1SORT1 | |
| SCHEMBL31331997 | 0.87 | KISS1R (0.62) | KISS1RTACR1NTSR2NTSR1SORT1 | |
| SCHEMBL29598567 | 0.86 | KISS1R (0.65) | KISS1RTACR1NTSR2NTSR1C5AR1 | |
| SCHEMBL31332280 | 0.86 | KISS1R (0.64) | KISS1RTACR1NTSR2NTSR1SORT1 | |
| SCHEMBL31186286 | 0.85 | KISS1R (0.65) | KISS1ROPRD1OPRM1TACR1NTSR2 | |
| SCHEMBL30007955 | 0.84 | NTSR2 (0.65) | KISS1ROPRM1TACR1NTSR2NTSR1 | |
| SCHEMBL29716634 | 0.84 | NTSR2 (0.75) | OPRD1OPRM1OPRK1TACR1NTSR2 | |
| SCHEMBL29535981 | 0.84 | TACR1 (0.78) | KISS1ROPRD1OPRM1OPRK1TACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250242039-A1 | TOXIN-DERIVED DELIVERY CONSTRUCTS | THORNHILL THERAPEUTICS INC (US) | 2025-07-31 | — | — | US | disclosed |
| US-20240299565-A1 | TOXIN-DERIVED DELIVERY CONSTRUCTS | APPLIED MOLECULAR TRANSPORT INC. | 2024-09-12 | — | — | US | disclosed |
| EP-4316586-A2 | TOXIN-DERIVED DELIVERY CONSTRUCTS FOR ORAL DELIVERY | Applied Molecular Transport Inc. (US) | 2024-02-07 | — | — | EP | disclosed |
| EP-4082558-B1 | TOXIN-DERIVED DELIVERY CONSTRUCTS FOR ORAL DELIVERY | APPLIED MOLECULAR TRANSPORT INC (US) | 2023-08-23 | — | — | EP | disclosed |
| US-20230158163-A1 | TOXIN-DERIVED DELIVERY CONSTRUCTS | THORNHILL THERAPEUTICS, INC. | 2023-05-25 | — | — | US | disclosed |
| EP-4082558-A1 | TOXIN-DERIVED DELIVERY CONSTRUCTS FOR ORAL DELIVERY | Applied Molecular Transport Inc. (US) | 2022-11-02 | — | — | EP | disclosed |
| US-11426466-B2 | Toxin-derived delivery constructs for pulmonary delivery | APPLIED MOLECULAR TRANSPORT INC. (US) | 2022-08-30 | — | — | US | disclosed |
| EP-3762009-B1 | TOXIN-DERIVED DELIVERY CONSTRUCTS FOR ORAL DELIVERY | APPLIED MOLECULAR TRANSPORT INC (US) | 2022-05-11 | — | — | EP | disclosed |